BridgeBio Pharma Inc (NASDAQ:BBIO)
| 8.96 BATS BZX Real-Time Price As of 12:27pm ET |  -0.39 / -4.17%Today’s Change | 4.98 Today|||52-Week Range 65.33 | -46.28% Year-to-Date |
Latest BBIO News | Press Releases
No recent news for BridgeBio Pharma Inc.
Today’s Trading
| Previous close | 9.35 |
| Today’s open | 9.41 |
| Day’s range | 8.86 - 9.54 |
| Volume | 67,951 |
| Average volume (3 months) | 2,422,769 |
| Market cap | $1.4B |
Data as of 12:27pm ET, 06/28/2022
Growth & Valuation
| Earnings growth (last year) | -2.47% |
| Earnings growth (this year) | +7.99% |
| Earnings growth (next 5 years) | -51.17% |
| Revenue growth (last year) | +745.14% |
| P/E ratio | NM |
| Price/Sales | 34.54 |
| Price/Book | -- |
Competitors
| ---- | ||
| IMMBImmunotech Laborator... | 0.00 | 0.00% |
| TEVATeva Pharmaceutical | -0.21 | -2.50% |
| BGNEBeigene Ltd | -9.42 | -5.50% |
Data as of 12:28pm ET, 06/28/2022
Financials
| Next reporting date | August 16, 2022 |
| EPS forecast (this quarter) | -$0.60 |
| Annual revenue (last year) | $69.7M |
| Annual profit (last year) | -$562.5M |
| Net profit margin | -806.90% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Palo Alto, California |
Forecasts
